Study Comparing the Safety and Efficacy of Belatacept (LEA29Y; BMS-224818) to Cyclosporine, in Patients Receiving a Kidney Transplant, When Used in Combination With CellCept, Simulect, and Corticosteroids.
This study is ongoing, but not recruiting participants.
Study NCT00035555
Information provided by Bristol-Myers Squibb
First Received on May 3, 2002.
Last Updated on January 26, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
